# Justus Duyster

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/justus-duyster/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,434 |
| Field | Chronic Myeloid Leukemia Treatments |
| h-index | 68 |
| i10-index | 229 |
| Last Known Institution | University of Freiburg |
| OpenAlex ID | https://openalex.org/A5088789978 |
| ORCID iD | https://orcid.org/0000-0001-7325-7753 |
| Works | 568 |

## Researcher papers

- [Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma](https://scholariq.org/papers/combination-of-lenvatinib-and-pembrolizumab-is-an-effective-treatment-option-for/)
- [Oncogenic JAK2 <sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms](https://scholariq.org/papers/oncogenic-jak2-sup-v617f-sup-causes-pd-l1-expression-mediating-immune-escape-in/)

## Researcher topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Researcher university

- [University of Freiburg](https://scholariq.org/institutions/university-of-freiburg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.